Latest Report Update: Apr 8, 2021

France - Vaccines For Human Medicine - Market Analysis, Forecast, Size, Trends and Insights
Update: COVID-19 Impact

Licenses

You will receive a PDF copy of the report by email within 24 hours (Mon - Fri).

By clicking «Buy the Report», you agree to our Terms of Service and Privacy Policy. We'll occasionally send you account related emails.

France: Vaccine Market Overview 2021

Vaccine Market Size in France

After two years of growth, the French vaccine market decreased by -X% to $X in 2019. In general, the total consumption indicated a tangible expansion from 2007 to 2019: its value decreased at an average annual rate of -X% over the last twelve-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. The growth pace was the most rapid in 2017 when the market value increased by X% year-to-year. Over the period under review, the market hit record highs at $X in 2018, and then contracted in the following year.

Vaccine Production in France

In value terms, vaccine production amounted to $X in 2019 estimated in export prices. In general, the total production indicated a temperate increase from 2007 to 2019: its value increased at an average annual rate of +X% over the last twelve-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2019 figures, production decreased by -X% against 2014 indices. The pace of growth appeared the most rapid in 2014 when the production volume increased by X% y-o-y. As a result, production attained the peak level of $X. From 2015 to 2019, production growth failed to regain the momentum.

Vaccine Exports

Exports from France

In 2019, shipments abroad of vaccines for human medicine increased by X% to X tonnes for the first time since 2016, thus ending a two-year declining trend. In general, exports enjoyed noticeable growth. The most prominent rate of growth was recorded in 2009 with an increase of X% y-o-y. Exports peaked at X tonnes in 2014; however, from 2015 to 2019, exports failed to regain the momentum.

In value terms, vaccine exports stood at $X in 2019. Over the period under review, exports enjoyed a prominent expansion. The growth pace was the most rapid in 2009 with an increase of X% against the previous year. Exports peaked at $X in 2013; however, from 2014 to 2019, exports failed to regain the momentum.

Exports by Country

Belgium (X tonnes) was the main destination for vaccine exports from France, accounting for a X% share of total exports. Moreover, vaccine exports to Belgium exceeded the volume sent to the second major destination, the UK (X tonnes), more than tenfold. Ireland (X tonnes) ranked third in terms of total exports with a X% share.

From 2007 to 2019, the average annual rate of growth in terms of volume to Belgium totaled +X%. Exports to the other major destinations recorded the following average annual rates of exports growth: the UK (+X% per year) and Ireland (+X% per year).

In value terms, Belgium ($X) remains the key foreign market for vaccine exports from France, comprising X% of total exports. The second position in the ranking was occupied by China ($X), with a X% share of total exports. It was followed by Germany, with a X% share.

From 2007 to 2019, the average annual rate of growth in terms of value to Belgium totaled +X%. Exports to the other major destinations recorded the following average annual rates of exports growth: China (+X% per year) and Germany (+X% per year).

Export Prices by Country

In 2019, the average vaccine export price amounted to $X per tonne, shrinking by -X% against the previous year. Over the period under review, export price indicated a temperate expansion from 2007 to 2019: its price increased at an average annual rate of +X% over the last twelve years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2019 figures, vaccine export price increased by +X% against 2014 indices. The most prominent rate of growth was recorded in 2010 when the average export price increased by X% y-o-y. Over the period under review, average export prices attained the peak figure at $X per tonne in 2018, and then fell in the following year.

There were significant differences in the average prices for the major foreign markets. In 2019, the country with the highest price was China ($X per tonne), while the average price for exports to Ireland ($X per tonne) was amongst the lowest.

From 2007 to 2019, the most notable rate of growth in terms of prices was recorded for supplies to China, while the prices for the other major destinations experienced more modest paces of growth.

Vaccine Imports

Imports into France

In 2019, overseas purchases of vaccines for human medicine increased by X% to X tonnes, rising for the second year in a row after four years of decline. Overall, imports saw a notable expansion. The pace of growth appeared the most rapid in 2009 when imports increased by X% y-o-y. Imports peaked at X tonnes in 2013; however, from 2014 to 2019, imports remained at a lower figure.

In value terms, vaccine imports expanded modestly to $X in 2019. Over the period under review, imports showed strong growth. The most prominent rate of growth was recorded in 2009 when imports increased by X% y-o-y. Over the period under review, imports hit record highs at $X in 2013; however, from 2014 to 2019, imports failed to regain the momentum.

Imports by Country

In 2019, Belgium (X tonnes) constituted the largest vaccine supplier to France, with a X% share of total imports. Moreover, vaccine imports from Belgium exceeded the figures recorded by the second-largest supplier, Italy (X tonnes), fivefold. The UK (X tonnes) ranked third in terms of total imports with a X% share.

From 2007 to 2019, the average annual rate of growth in terms of volume from Belgium totaled +X%. The remaining supplying countries recorded the following average annual rates of imports growth: Italy (-X% per year) and the UK (+X% per year).

In value terms, Belgium ($X) constituted the largest supplier of vaccine to France, comprising X% of total imports. The second position in the ranking was occupied by the UK ($X), with a X% share of total imports. It was followed by Canada, with a X% share.

From 2007 to 2019, the average annual growth rate of value from Belgium amounted to +X%. The remaining supplying countries recorded the following average annual rates of imports growth: the UK (+X% per year) and Canada (+X% per year).

Import Prices by Country

The average vaccine import price stood at $X per tonne in 2019, remaining constant against the previous year. In general, the import price showed a resilient expansion. The most prominent rate of growth was recorded in 2015 an increase of X% year-to-year. The import price peaked at $X per tonne in 2017; however, from 2018 to 2019, import prices remained at a lower figure.

There were significant differences in the average prices amongst the major supplying countries. In 2019, the country with the highest price was the UK ($X per tonne), while the price for Italy ($X per tonne) was amongst the lowest.

From 2007 to 2019, the most notable rate of growth in terms of prices was attained by Canada, while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox AI Platform

Frequently Asked Questions (FAQ) :

What are the largest markets for vaccines for human medicine in the world?
+
The countries with the highest volumes of human medicine vaccines consumption in 2019 were Belgium (26K tonnes), China (20K tonnes) and India (8K tonnes), together accounting for 47% of global consumption.
What are the largest producers of vaccines for human medicine in the world?
+
The countries with the highest volumes of human medicine vaccines production in 2019 were Ireland (31K tonnes), China (19K tonnes) and India (12K tonnes), with a combined 52% share of global production. The UK, Belgium, the U.S., France, Russia, Indonesia, Japan and Mexico lagged somewhat behind, together comprising a further 37%.
What are the leading suppliers of vaccines for human medicine to France?
+
In value terms, Belgium ($472M) constituted the largest supplier of human medicine vaccines to France, comprising 63% of total imports. The second position in the ranking was occupied by the UK ($115M), with a 15% share of total imports. It was followed by Canada, with a 6.6% share.
What are the leading importers of vaccines for human medicine from France?
+
In value terms, Belgium ($2.2B) remains the key foreign market for human medicine vaccines exports from France, comprising 42% of total exports. The second position in the ranking was occupied by China ($284M), with a 5.5% share of total exports. It was followed by Germany, with a 3.1% share.
What is the average export price for vaccines for human medicine in France?
+
The average human medicine vaccines export price stood at $881,315 per tonne in 2019, increasing by 5.4% against the previous year.
What is the average import price for vaccines for human medicine in France?
+
In 2019, the average human medicine vaccines import price amounted to $234,342 per tonne, shrinking by -5.7% against the previous year.

Product coverage:
• Prodcom 21202140 -
• Prodcom 21202145 - Vaccines for human medicine

This report provides an in-depth analysis of the vaccine market in France. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2025.


Country coverage:
• France

Data coverage:
• Market volume and value
• Per Capita consumption
• Forecast of the market dynamics in the medium term
• Trade (exports and imports) in France
• Export and import prices
• Market trends, drivers and restraints
• Key market players and their profiles

Reasons to buy this report:
• Take advantage of the latest data
• Find deeper insights into current market developments
• Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:
1. How to diversify your business and benefit from new market opportunities
2. How to load your idle production capacity
3. How to boost your sales on overseas markets
4. How to increase your profit margins
5. How to make your supply chain more sustainable
6. How to reduce your production and supply chain costs
7. How to outsource production to other countries
8. How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
1. INTRODUCTION

Making Data-Driven Decisions to Grow Your Business

1.1
REPORT DESCRIPTION
1.2
RESEARCH METHODOLOGY AND AI PLATFORM
1.3
DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
1.4
GLOSSARY AND SPECIFIC TERMS
2. EXECUTIVE SUMMARY

A Quick Overview of Market Performance

2.1
KEY FINDINGS
2.2
MARKET TRENDS
3. MARKET OVERVIEW

Understanding the Current State of The Market and Its Prospects

3.1
MARKET SIZE
3.2
MARKET STRUCTURE
3.3
TRADE BALANCE
3.4
PER CAPITA CONSUMPTION
3.5
MARKET FORECAST TO 2030
4. MOST PROMISING PRODUCTS

Finding New Products to Diversify Your Business

4.1
TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
4.2
BEST-SELLING PRODUCTS
4.3
MOST CONSUMED PRODUCT
4.4
MOST TRADED PRODUCT
4.5
MOST PROFITABLE PRODUCT FOR EXPORT
5. MOST PROMISING SUPPLYING COUNTRIES

Choosing the Best Countries to Establish Your Sustainable Supply Chain

5.1
TOP COUNTRIES TO SOURCE YOUR PRODUCT
5.2
TOP PRODUCING COUNTRIES
5.3
TOP EXPORTING COUNTRIES
5.4
LOW-COST EXPORTING COUNTRIES
6. MOST PROMISING OVERSEAS MARKETS

Choosing the Best Countries to Boost Your Exports

6.1
TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
6.2
TOP CONSUMING MARKETS
6.3
UNSATURATED MARKETS
6.4
TOP IMPORTING MARKETS
6.5
MOST PROFITABLE MARKETS
7. PRODUCTION

The Latest Trends and Insights into The Industry

7.1
PRODUCTION VOLUME AND VALUE
8. IMPORTS

The Largest Import Supplying Countries

8.1
IMPORTS FROM 2007–2020
8.2
IMPORTS BY COUNTRY
8.3
IMPORT PRICES BY COUNTRY
9. EXPORTS

The Largest Destinations for Exports

9.1
EXPORTS FROM 2007–2020
9.2
EXPORTS BY COUNTRY
9.3
EXPORT PRICES BY COUNTRY
10. PROFILES OF MAJOR PRODUCERS

The Largest Producers on The Market and Their Profiles

LIST OF TABLES
Table 1:
Key Findings In 2020
Table 2:
Market Volume, In Physical Terms, 2007–2020
Table 3:
Market Value, 2007–2020
Table 4:
Per Capita Consumption In 2007–2020
Table 5:
Imports, In Physical Terms, By Country, 2007–2020
Table 6:
Imports, In Value Terms, By Country, 2007–2020
Table 7:
Import Prices, By Country Of Origin, 2007–2020
Table 8:
Exports, In Physical Terms, By Country, 2007–2020
Table 9:
Exports, In Value Terms, By Country, 2007–2020
Table 10:
Export Prices, By Country Of Destination, 2007–2020
LIST OF FIGURES
Figure 1:
Market Volume, In Physical Terms, 2007–2020
Figure 2:
Market Value, 2007–2020
Figure 3:
Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2007–2020
Figure 4:
Market Structure – Domestic Supply vs. Imports, In Value Terms, 2007–2020
Figure 5:
Trade Balance, In Physical Terms, 2007–2020
Figure 6:
Trade Balance, In Value Terms, 2007–2020
Figure 7:
Per Capita Consumption, 2007–2020
Figure 8:
Market Forecast To 2025
Figure 9:
Products: Market Size And Growth, By Type
Figure 10:
Products: Average Per Capita Consumption, By Type
Figure 11:
Products: Exports And Growth, By Type
Figure 12:
Products: Export Prices And Growth, By Type
Figure 13:
Production Volume And Growth
Figure 14:
Exports And Growth
Figure 15:
Export Prices And Growth
Figure 16:
Market Size And Growth
Figure 17:
Per Capita Consumption
Figure 18:
Imports And Growth
Figure 19:
Import Prices
Figure 20:
Production, In Physical Terms, 2007–2020
Figure 21:
Production, In Value Terms, 2007–2020
Figure 22:
Imports, In Physical Terms, 2007–2020
Figure 23:
Imports, In Value Terms, 2007–2020
Figure 24:
Imports, In Physical Terms, By Country, 2020
Figure 25:
Imports, In Physical Terms, By Country, 2007–2020
Figure 26:
Imports, In Value Terms, By Country, 2007–2020
Figure 27:
Import Prices, By Country Of Origin, 2007–2020
Figure 28:
Exports, In Physical Terms, 2007–2020
Figure 29:
Exports, In Value Terms, 2007–2020
Figure 30:
Exports, In Physical Terms, By Country, 2020
Figure 31:
Exports, In Physical Terms, By Country, 2007–2020
Figure 32:
Exports, In Value Terms, By Country, 2007–2020
Figure 33:
Export Prices, By Country Of Destination, 2007–2020

Webinar: Global Graphite Market - Statistics, Trends, and Outlook



Join our live webinar to get insights into the global graphite market.



Tuesday, May 18th, 2021 @ 04:00 pm ET


Register

Webinar: Global Coal Market - Statistics, Trends, and Outlook



Join our live webinar to get insights into the global сoal market.



Tuesday, June 1st, 2021 @ 04:00 pm ET


Register

Webinar: Global Biodiesel Market - Statistics, Trends, and Outlook



Join our live webinar to get insights into the global biodiesel market.



Thursday, June 10th, 2021 @ 04:00 pm ET


Register
Ready to Get Started?
We can help you conduct market research and write a report using the most reliable data